PHILIP BORDERS: Open Payments
NPI 1881608933 · PLAINFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,598 in 159 payments from 21 companies in 2025. Trend: 2023 $3,062 · 2024 $2,392 · 2025 $2,598
Food & beverage: $2,508Education: $90
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 16 | $370 |
| Otsuka America Pharmaceutical, Inc. | 20 | $313 |
| Supernus Pharmaceuticals, Inc. | 27 | $296 |
| Corium, LLC | 17 | $245 |
| Teva Pharmaceuticals USA, Inc. | 7 | $207 |
| Lundbeck LLC | 9 | $170 |
| Vanda Pharmaceuticals Inc. | 7 | $156 |
| Collegium Pharmaceutical, Inc. | 19 | $139 |
| Neurocrine BioSciences, Inc. | 7 | $135 |
| Noven Therapeutics, LLC | 5 | $89 |
Products named: REXULTI, Auvelity, Qelbree, Azstarys, HETLIOZ, Jornay PM, INGREZZA, AUSTEDO XR.
Industry payments across IN — which companies pay providers there.
